WallStreetZenWallStreetZen

NASDAQ: EYPT
Eyepoint Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for EYPT

Based on 2 analysts offering 12 month price targets for Eyepoint Pharmaceuticals Inc.
Min Forecast
$21.00+223.08%
Avg Forecast
$23.00+253.85%
Max Forecast
$25.00+284.62%

Should I buy or sell EYPT stock?

Based on 2 analysts offering ratings for Eyepoint Pharmaceuticals Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their EYPT stock forecasts and price targets.

EYPT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Top 5%
96
BuyMaintains$25.00+284.62%2022-08-04
Chardan Capital
Bottom 15%
15
Strong BuyInitiates Coverage On$21.00+223.08%2022-07-07

1 of 1

Forecast return on equity

Is EYPT forecast to generate an efficient return?
Company
-61.23%
Industry
-11.33%
Market
100.32%
EYPT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is EYPT forecast to generate an efficient return on assets?
Company
-39.7%
Industry
-5.09%
EYPT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

EYPT earnings per share forecast

What is EYPT's earnings per share in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$2.43
Avg 2 year Forecast
-$2.72

EYPT revenue forecast

What is EYPT's revenue in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
$43.6M+5.04%
Avg 2 year Forecast
$51.1M+23.12%
EYPT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

EYPT revenue growth forecast

How is EYPT forecast to perform vs Biotechnology companies and vs the US market?
Company
5.04%
Industry
39.71%
Market
15.15%
EYPT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
EYPT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

EYPT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
EYPT$6.50$23.00+253.85%Strong Buy
VKTX$2.90$11.00+279.31%Buy
THRX$5.75$24.40+324.35%Strong Buy
XERS$1.61$5.98+271.12%Strong Buy
LIAN$2.07$23.19+1,020.43%Buy

Eyepoint Pharmaceuticals Stock Forecast FAQ

Is Eyepoint Pharmaceuticals Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: EYPT) stock is to Strong Buy EYPT stock.

Out of 2 analysts, 1 (50%) are recommending EYPT as a Strong Buy, 1 (50%) are recommending EYPT as a Buy, 0 (0%) are recommending EYPT as a Hold, 0 (0%) are recommending EYPT as a Sell, and 0 (0%) are recommending EYPT as a Strong Sell.

If you're new to stock investing, here's how to buy Eyepoint Pharmaceuticals stock.

What is EYPT's earnings growth forecast for 2022-2023?

(NASDAQ: EYPT) Eyepoint Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 18.81%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 52.44%.

Eyepoint Pharmaceuticals's earnings in 2022 is -$76,509,000.On average, 2 Wall Street analysts forecast EYPT's earnings for 2022 to be -$82,794,715, with the lowest EYPT earnings forecast at -$83,816,872, and the highest EYPT earnings forecast at -$81,772,558.

In 2023, EYPT is forecast to generate -$92,675,565 in earnings, with the lowest earnings forecast at -$106,645,044 and the highest earnings forecast at -$74,958,178.

What is EYPT's revenue growth forecast for 2022-2023?

(NASDAQ: EYPT) Eyepoint Pharmaceuticals's forecast annual revenue growth rate of 5.04% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 39.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.15%.

Eyepoint Pharmaceuticals's revenue in 2022 is $41,462,000.On average, 2 Wall Street analysts forecast EYPT's revenue for 2022 to be $1,483,831,201, with the lowest EYPT revenue forecast at $1,400,355,049, and the highest EYPT revenue forecast at $1,567,307,354.

In 2023, EYPT is forecast to generate $1,739,370,444 in revenue, with the lowest revenue forecast at $1,597,972,063 and the highest revenue forecast at $1,880,768,825.

What is EYPT's forecast return on assets (ROA) for 2022-2023?

(NASDAQ: EYPT) forecast ROA is -39.7%, which is lower than the forecast US Biotechnology industry average of -5.09%.

What is EYPT's Price Target?

According to 2 Wall Street analysts that have issued a 1 year EYPT price target, the average EYPT price target is $23.00, with the highest EYPT stock price forecast at $25.00 and the lowest EYPT stock price forecast at $21.00.

On average, Wall Street analysts predict that Eyepoint Pharmaceuticals's share price could reach $23.00 by Aug 4, 2023. The average Eyepoint Pharmaceuticals stock price prediction forecasts a potential upside of 253.85% from the current EYPT share price of $6.50.

What is EYPT's Earnings Per Share (EPS) forecast for 2022-2023?

(NASDAQ: EYPT) Eyepoint Pharmaceuticals's current Earnings Per Share (EPS) is -$2.27. On average, analysts forecast that EYPT's EPS will be -$2.43 for 2022, with the lowest EPS forecast at -$2.46, and the highest EPS forecast at -$2.40. In 2023, EYPT's EPS is forecast to hit -$2.72 (min: -$3.13, max: -$2.20).

What is EYPT's forecast return on equity (ROE) for 2022-2023?

(NASDAQ: EYPT) forecast ROE is -61.23%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.